Resyno One Mechanism of Action

Hyaluronic acid is a naturally occurring polysaccharide that exists in many connective tissues such as joint fluid and serves to provide viscoelasticity of joint synovial fluid.
Trauma and degenerative joint diseases reduce hyaluronic acid in the joints and cannot absorb or disperse impacts, resulting in joint damage, which is a source of pain. Intraarticular administration of sodium hyaluronate can replace (substitute) synovial fluid as viscoelastic supplement.
Clinical Benefit: In the treatment of knee osteoarthritis, hyaluronic acid preparations have shown results in various clinical studies indicating improvements in pain and physical function compared to baseline values.
Resyno One Inj. has shown comparable pain relief effects up to 12 weeks in clinical trials compared to similar hyaluronic acid preparations. Furthermore, in the results after 24 weeks of re-administration, it showed even better improvements compared to the control group, and no serious adverse reactions were observed.